We would love to hear your thoughts about our site and services, please take our survey here.
What have PH have to do with the SP of Sensyne, are you blaming JP Morgan too? as JP are also Joint advisors.
looking into Sensyne, simply they are running out of money, they have "possible" contracts of £28m waiting on the wings, but are not committing to the company until it sorts its finances out.
I would say its simple a matter of the companies survival
Just like sar up until this year have had to be careful with their cash and prioritise their pipeline
When we had chk1 that took most of our money and aurora. Tyk2 was on the back burner for many years.
Similar sierra are prioritising momo.with final data due next month and if that goes well, they know FDA has fast tracked it and that drug could the market within 18 months so guaranteed major revenue.
They can then focus on chk1
However it will be interesting to see what happens to sierra if momo fails .
RMM for your posts
@belhus
for sierra Next month is make or break time for them
this is when they expect
pivotal Phase 3 MOMENTUM data
– High probability of success trial; FDA approval and launch expected <18 months
think thats the key that will unlock their strategy going forward.
interesting is that Esker was only formed in 2021
and they dont have any patent protection in place....
https://www.evaluate.com/vantage/articles/interviews/esker-joins-tyk2-race
Nubex
No worries, its always worth bearing in mind until the arrival of the hnwis this year pumping in serious money, sar have always had to do with the tightest of budgets with a small team. Always hard to make quick progress when there are limitations in place
But now the landscape is different, they can think bigger and not feel forced Into any deal they don't like. They can take time and makes sure they get it right.
i do feel for you Nubex
you took part in the primarybid offer and bought in at 0.6p
todays share price is 5P
and during the year it went up twice to 9p
yep its a struggle.
regarding Agile- SAR already said, you cant enter Agile unless the preclinical work is done..
from your post about delays etc..they've already explained it at the AGM, im assuming you watched that and read the Q&As?
things first
Sierras pipeline
https://www.sierraoncology.com/science/#pipeline
secondly trial status
https://clinicaltrials.gov/ct2/results?cond=&term=sra737&cntry=&state=&city=&dist=
both trials- data submitted 16th November
and better news already Phase 2 as complete..